Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Cancer Screening Using Single-Molecule Enzyme Activity-Based Liquid Biopsy, Enzeavour: A Single-Arm Interventional Feasibility Study Protocol in Japan

NCT07605819 is registered in ClinicalTrials.gov with Cosomil, Inc. as lead sponsor.

NCT NCT07605819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07605819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Cancer Screening Using Single-Molecule Enzyme Activity-Based Liquid Biopsy, Enzeavour: A Single-Arm Interventional Feasibility Study Protocol in Japan
Lead sponsor
Cosomil, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
February 4, 2026
Completion date
December 31, 2028
Enrollment
10,000 (estimated)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, pancreatic neoplasms